Hans Prenen

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 31

Top Venues

Pharmaceuticals (Basel, Switzerland)

Science advances

Cancers

Clinical cancer research : an official journal of the American Association for Cancer Research

University Hospital Antwerp

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University Hospital Antwerp May 01 2018

Belgium

Head of Phase I - Early Clinical Trials Unit :: Oncology

University Hospitals Gasthuisberg Mar 01 2008 - Apr 30 2018

Belgium

MD, PhD :: Oncology

Publications

Danielle Delombaerde, Christof Vulsteke, Nico Van de Veire, Delphine Vervloet, Veronique Moerman, Lynn Van Calster, Anne-Marie Willems, Lieselot Croes, Félix Gremonprez, Astrid De Meulenaere, Ximena Elzo Kraemer, Kristien Wouters, Marc Peeters, Hans Prenen, Johan De Sutter
Close Cardiovascular Monitoring during the Early Stages of Treatment for Patients Receiving Immune Checkpoint Inhibitors. Pharmaceuticals (Basel, Switzerland) 17 (7) (2024)
Danielle Delombaerde, Christof Vulsteke, Nico Van de Veire, Delphine Vervloet, Veronique Moerman, Lynn Van Calster, Anne-Marie Willems, Lieselot Croes, Félix Gremonprez, Astrid De Meulenaere, Ximena Elzo Kraemer, Kristien Wouters, Marc Peeters, Hans Prenen, Johan De Sutter
Close Cardiovascular Monitoring during the Early Stages of Treatment for Patients Receiving Immune Checkpoint Inhibitors. Pharmaceuticals (Basel, Switzerland) 17 (7) (2024)
Alexander M Menzies, Georgina V Long, Amiee Kohn, Hussein A Tawbi, Jeffrey Weber, Keith Flaherty, Grant A McArthur, Paolo A Ascierto, Yanina Pfluger, Karl Lewis, Katy K Tsai, Omid Hamid, Hans Prenen, Luis Fein, Erjian Wang, Carolin Guenzel, Fan Zhang, Joseph F Kleha, Alessandra di Pietro, Michael A Davies
POLARIS: A phase 2 trial of encorafenib plus binimetinib evaluating high-dose and standard-dose regimens in patients with BRAF V600-mutant melanoma with brain metastasis. Neuro-oncology advances 6 (1) (2024)
Brian Belmontes, Katherine K Slemmons, Chun Su, Siyuan Liu, Antonia N Policheni, Jodi Moriguchi, Hong Tan, Fang Xie, Daniel Andrew Aiello, Yajing Yang, Raul Lazaro, Famke Aeffner, Matthew G Rees, Melissa A Ronan, Jennifer A Roth, Mikkel Vestergaard, Sanne Cowland, Jan Andersson, Ian Sarvary, Qing Chen, Pooja Sharma, Patricia Lopez, Nuria A Tamayo, Liping H Pettus, Sudipa Ghimire-Rijal, Susmith Mukund, Jennifer R Allen, Jason DeVoss, Angela Coxon, Jordi Rodon Ahnert, François Ghiringhelli, Nicolas Penel, Hans Prenen, Sanne Glad, Chen-Hua Chuang, Kiana Keyvanjah, Danielle M Townsley, John R Butler, Matthew P Bourbeau, Sean Caenepeel, Paul E Hughes
AMG 193, a Clinical Stage MTA-Cooperative PRMT5 Inhibitor, Drives Antitumor Activity Preclinically and in Patients With MTAP-Deleted Cancers. Cancer discovery (2024)
Hans Prenen, Sanjeev Deva, Bhumsuk Keam, Colin R Lindsay, Iwona Lugowska, James Chih-Hsin Yang, Federico Longo, Maria J de Miguel Luken, Mariano Ponz-Sarvisé, Myung-Ju Ahn, Mahmut Gümüş, Stephane Champiat, Antoine Italiano, Sebastien Salas, Ruth Perets, Cagatay Arslan, Byoung Chul Cho, Stefan Evers, Christophe Boetsch, Daniel Marbach, David Dejardin, Nassim Sleiman, Caroline Ardeshir, Muriel Richard, Jehad Charo, Anton Kraxner, Nino Keshelava, Volker Teichgräber, Victor Moreno
Phase II study to determine the anti-tumor activity and safety of simlukafusp alfa (FAP-IL2v) combined with atezolizumab in esophageal cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Denise van der Graaff, Sofie Seghers, Pieterjan Vanclooster, Christophe Deben, Timon Vandamme, Hans Prenen
Advancements in Research and Treatment Applications of Patient-Derived Tumor Organoids in Colorectal Cancer. Cancers 16 (15) (2024)
Danielle Delombaerde, Christof Vulsteke, Nico Van de Veire, Delphine Vervloet, Veronique Moerman, Lynn Van Calster, Anne-Marie Willems, Lieselot Croes, Félix Gremonprez, Astrid De Meulenaere, Ximena Elzo Kraemer, Kristien Wouters, Marc Peeters, Hans Prenen, Johan De Sutter
Close Cardiovascular Monitoring during the Early Stages of Treatment for Patients Receiving Immune Checkpoint Inhibitors. Pharmaceuticals (Basel, Switzerland) 17 (7) (2024)
Denise van der Graaff, Sofie Seghers, Pieterjan Vanclooster, Christophe Deben, Timon Vandamme, Hans Prenen
Advancements in Research and Treatment Applications of Patient-Derived Tumor Organoids in Colorectal Cancer. Cancers 16 (15) (2024)
Alexander M Menzies, Georgina V Long, Amiee Kohn, Hussein A Tawbi, Jeffrey Weber, Keith Flaherty, Grant A McArthur, Paolo A Ascierto, Yanina Pfluger, Karl Lewis, Katy K Tsai, Omid Hamid, Hans Prenen, Luis Fein, Erjian Wang, Carolin Guenzel, Fan Zhang, Joseph F Kleha, Alessandra di Pietro, Michael A Davies
POLARIS: A phase 2 trial of encorafenib plus binimetinib evaluating high-dose and standard-dose regimens in patients with BRAF V600-mutant melanoma with brain metastasis. Neuro-oncology advances 6 (1) (2024)
Hans Prenen, Sanjeev Deva, Bhumsuk Keam, Colin R Lindsay, Iwona Lugowska, James Chih-Hsin Yang, Federico Longo, Maria J de Miguel Luken, Mariano Ponz-Sarvisé, Myung-Ju Ahn, Mahmut Gümüş, Stephane Champiat, Antoine Italiano, Sebastien Salas, Ruth Perets, Cagatay Arslan, Byoung Chul Cho, Stefan Evers, Christophe Boetsch, Daniel Marbach, David Dejardin, Nassim Sleiman, Caroline Ardeshir, Muriel Richard, Jehad Charo, Anton Kraxner, Nino Keshelava, Volker Teichgräber, Victor Moreno
Phase II Study to Determine the Antitumor Activity and Safety of Simlukafusp Alfa (FAP-IL2v) Combined with Atezolizumab in Esophageal Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (14) (2024)
Melinda A Pruis, Matthew G Krebs, Ruth Plummer, Filip Yves Francine De Vos, Eric Angevin, Hans Prenen, Martin D Forster, Glen Clack, Annegret Van der Aa, Marc Tjwa, Ellen Jansen, Timothy Perera, Martijn Paul Lolkema
A Phase I Trial of the Dual MET Kinase/OCT-2 Inhibitor OMO-1 in Metastatic Solid Malignancies Including MET Exon 14 Mutated Lung Cancer. The oncologist (2023)
Danielle Delombaerde, Johan De Sutter, Lieselot Croes, Delphine Vervloet, Veronique Moerman, Nico Van de Veire, Anne-Marie Willems, Kristien Wouters, Marc Peeters, Hans Prenen, Christof Vulsteke
Extensive CArdioVAscular Characterization and Follow-Up of Patients Receiving Immune Checkpoint Inhibitors: A Prospective Multicenter Study. Pharmaceuticals (Basel, Switzerland) 16 (4) (2023)
Laure-Anne Teuwen, Evelyne Roets, Pieter D'Hoore, Patrick Pauwels, Hans Prenen
Comprehensive Genomic Profiling and Therapeutic Implications for Patients with Advanced Cancers: The Experience of an Academic Hospital. Diagnostics (Basel, Switzerland) 13 (9) (2023)
Carla Riera-Domingo, Eduarda Leite-Gomes, Iris Charatsidou, Peihua Zhao, Giovanna Carrà, Federica Cappellesso, Larissa Mourao, Maxim De Schepper, Dana Liu, Jens Serneels, Mohamad Gabriel Alameh, Vladimir V Shuvaev, Tatjana Geukens, Edoardo Isnaldi, Hans Prenen, Drew Weissman, Vladimir R Muzykantov, Stefaan J Soenen, Christine Desmedt, Colinda L G J Scheele, Anna A Sablina, Mario Di Matteo, Rosa Martín-Pérez, Massimilliano Mazzone
Breast tumors interfere with endothelial TRAIL at the premetastatic niche to promote cancer cell seeding. Science advances 9 (12) (2023)
Danielle Delombaerde, Johan De Sutter, Lieselot Croes, Delphine Vervloet, Veronique Moerman, Nico Van de Veire, Anne-Marie Willems, Kristien Wouters, Marc Peeters, Hans Prenen, Christof Vulsteke
Extensive CArdioVAscular Characterization and Follow-Up of Patients Receiving Immune Checkpoint Inhibitors: A Prospective Multicenter Study. Pharmaceuticals (Basel, Switzerland) 16 (4) (2023)
Danielle Delombaerde, Johan De Sutter, Lieselot Croes, Delphine Vervloet, Veronique Moerman, Nico Van de Veire, Anne-Marie Willems, Kristien Wouters, Marc Peeters, Hans Prenen, Christof Vulsteke
Extensive CArdioVAscular Characterization and Follow-Up of Patients Receiving Immune Checkpoint Inhibitors: A Prospective Multicenter Study. Pharmaceuticals (Basel, Switzerland) 16 (4) (2023)
Laure-Anne Teuwen, Evelyne Roets, Pieter D'Hoore, Patrick Pauwels, Hans Prenen
Comprehensive Genomic Profiling and Therapeutic Implications for Patients with Advanced Cancers: The Experience of an Academic Hospital. Diagnostics (Basel, Switzerland) 13 (9) (2023)
Carla Riera-Domingo, Eduarda Leite-Gomes, Iris Charatsidou, Peihua Zhao, Giovanna Carrà, Federica Cappellesso, Larissa Mourao, Maxim De Schepper, Dana Liu, Jens Serneels, Mohamad Gabriel Alameh, Vladimir V Shuvaev, Tatjana Geukens, Edoardo Isnaldi, Hans Prenen, Drew Weissman, Vladimir R Muzykantov, Stefaan J Soenen, Christine Desmedt, Colinda L G J Scheele, Anna A Sablina, Mario Di Matteo, Rosa Martín-Pérez, Massimilliano Mazzone
Breast tumors interfere with endothelial TRAIL at the premetastatic niche to promote cancer cell seeding. Science advances 9 (12) (2023)
Katleen Janssens, Chinouk Lambrechts, Barbara Geerinckx, Ken Op de Beeck, Guy Van Camp, Helena Oliveres, Hans Prenen, Timon Vandamme, Marc Peeters
New Developments in Treating RAS-Mutated Metastatic Colorectal Cancer. Current treatment options in oncology (2023)
Danielle Delombaerde, Johan De Sutter, Lieselot Croes, Delphine Vervloet, Veronique Moerman, Nico Van de Veire, Anne-Marie Willems, Kristien Wouters, Marc Peeters, Hans Prenen, Christof Vulsteke
Extensive CArdioVAscular Characterization and Follow-Up of Patients Receiving Immune Checkpoint Inhibitors: A Prospective Multicenter Study. Pharmaceuticals (Basel, Switzerland) 16 (4) (2023)
Carla Riera-Domingo, Eduarda Leite-Gomes, Iris Charatsidou, Peihua Zhao, Giovanna Carrà, Federica Cappellesso, Larissa Mourao, Maxim De Schepper, Dana Liu, Jens Serneels, Mohamad Gabriel Alameh, Vladimir V Shuvaev, Tatjana Geukens, Edoardo Isnaldi, Hans Prenen, Drew Weissman, Vladimir R Muzykantov, Stefaan J Soenen, Christine Desmedt, Colinda L G J Scheele, Anna A Sablina, Mario Di Matteo, Rosa Martín-Pérez, Massimilliano Mazzone
Breast tumors interfere with endothelial TRAIL at the premetastatic niche to promote cancer cell seeding. Science advances 9 (12) (2023)
Yana Debie, Jonas R M Van Audenaerde, Timon Vandamme, Lieselot Croes, Laure-Anne Teuwen, Lise Verbruggen, Greetje Vanhoutte, Elly Marcq, Lisa Verheggen, Debbie Le Blon, Bart Peeters, Maria E Goossens, Pieter Pannus, Kevin K Ariën, Sébastien Anguille, Annelies Janssens, Hans Prenen, Evelien L J Smits, Christof Vulsteke, Eva Lion, Marc Peeters, Peter A van Dam
Humoral and cellular immune responses against SARS-CoV-2 after third dose BNT162b2 following double-dose vaccination with BNT162b2 versus ChAdOx1 in cancer patients. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Elisabeth Wyart, Myriam Y Hsu, Roberta Sartori, Erica Mina, Valentina Rausch, Elisa Sefora Pierobon, Mariarosa Mezzanotte, Camilla Pezzini, Laure B Bindels, Andrea Lauria, Fabio Penna, Emilio Hirsch, Miriam Martini, Massimilliano Mazzone, Antonella Roetto, Simonetta Geninatti Crich, Hans Prenen, Marco Sandri, Alessio Menga, Paolo Ettore Porporato
Iron supplementation is sufficient to rescue skeletal muscle mass and function in cancer cachexia. EMBO reports 23 (4) (2022)
Xiaoyu Wang, Puya Gharahkhani, David M Levine, Rebecca C Fitzgerald, Ines Gockel, Douglas A Corley, Harvey A Risch, Leslie Bernstein, Wong-Ho Chow, Lynn Onstad, Nicholas J Shaheen, Jesper Lagergren, Laura J Hardie, Anna H Wu, Paul David Peter Pharoah, Geoffrey Liu, Lesley Ann Anderson, Prasad G Iyer, Marilie D Gammon, Carlos Caldas, Weimin Ye, Hugh Barr, Paul Moayyedi, Rebecca Harrison, R G Peter Watson, Stephen E Attwood, Laura Chegwidden, Sharon B Love, David MacDonald, John deCaestecker, Hans Prenen, Katja Ott, Susanne Moebus, Marino Venerito, Hauke Lang, Rupert Mayershofer, Michael Knapp, Lothar Veits, Christian Gerges, Josef Weismüller, Matthias Reeh, Markus Maria Nöthen, Jakob R Izbicki, Hendrik Manner, Horst Neuhaus, Thomas Rösch, Anne C Böhmer, Arnulf H Hölscher, Mario Anders, Oliver Pech, Brigitte Schumacher, Claudia Schmidt, Thomas Schmidt, Tania Noder, Dietmar Lorenz, Michael Vieth, Andrea May, Timo Hess, Nicole Kreuser, Jessica Becker, Christian Ell, Ian P M Tomlinson, Claire Palles, Janusz A Jankowski, David C Whiteman, Stuart Macgregor, Johannes Schumacher, Thomas L Vaughan, Matthew F Buas, James Y Dai
eQTL Set-Based Association Analysis Identifies Novel Susceptibility Loci for Barrett Esophagus and Esophageal Adenocarcinoma. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 31 (9) (2022)
Andreas Domen, Delphine Quatannens, Sara R Zanivan, Christophe Deben, Jonas R M Van Audenaerde, Evelien Smits, An Wouters, Filip Lardon, Geert Roeyen, Yannick Verhoeven, Annelies Janssens, Timon Vandamme, Peter van Dam, Marc Peeters, Hans Prenen
Cancer-Associated Fibroblasts as a Common Orchestrator of Therapy Resistance in Lung and Pancreatic Cancer. Cancers 13 (5) (2021)
Laure Sorber, Karen Zwaenepoel, Julie Jacobs, Koen De Winne, Kaat Van Casteren, Elien Augustus, Filip Lardon, Hans Prenen, Marc Peeters, Jan P van Meerbeeck, Geert Roeyen, Christian C Rolfo, Patrick Pauwels
Specialized Blood Collection Tubes for Liquid Biopsy: Improving the Pre-analytical Conditions. Molecular diagnosis & therapy 24 (1) (2021)
Marika Rasschaert, Pieterjan Vanclooster, Tim Mertens, Ella Roelant, Katrien Lesage, Hans Prenen, Anke Verlinden, Ilse van Brussel, Jo Ravelingien, Annelies Janssens, Peter Van Dam, Marc Peeters
The tele-transition of toxicity management in routine oncology care during the severe acute respiratory syndrome (SARS-CoV-2) pandemic. British journal of cancer 124 (8) (2021)
Federico Virga, Federica Cappellesso, Benoît Stijlemans, Anne-Theres Henze, Rosa Trotta, Jonas R M Van Audenaerde, Ananda S Mirchandani, Manuel A Sanchez-Garcia, Jolien Vandewalle, Francesca Orso, Carla Riera-Domingo, Alberto Griffa, Cristina Ivan, Evelien L J Smits, Damya Laoui, Fabio Martelli, Lies Langouche, Greet Van den Berghe, Olivier Feron, Bart Ghesquiere, Hans Prenen, Claude Libert, Sarah R Walmsley, Cyril Corbet, Jo A Van Ginderachter, Mircea Ivan, Daniela Taverna, Massimilliano Mazzone
Macrophage miR-210 induction and metabolic reprogramming in response to pathogen interaction boost life-threatening inflammation. Science advances 7 (19) (2021)
Marissa Lam, Caroline Lum, Sarah Latham, Samuel Smith, Hans Prenen, Eva Segelov
Refractory Metastatic Colorectal Cancer: Current Challenges and Future Prospects. Cancer management and research 12 (2020)
Peter A van Dam, Yannick Verhoeven, Julie Jacobs, An Wouters, Wiebren Tjalma, Filip Lardon, Tim Van den Wyngaert, Jonatan Dewulf, Evelien L J Smits, Cécile Colpaert, Hans Prenen, Marc Peeters, Martin M Y Lammens, Xuan Bich Trinh
RANK-RANKL Signaling in Cancer of the Uterine Cervix: A Review. International journal of molecular sciences 20 (9) (2019)
Dominiek Smeets, Ian S Miller, Aisling E O'Connor, Sudipto Das, Bruce Moran, Bram Boeckx, Timo Gaiser, Johannes Betge, Ana Barat, Rut Klinger, Nicole C T van Grieken, Chiara Cremolini, Hans Prenen, Massimiliano Mazzone, Jeroen Depreeuw, Orna Bacon, Bozena Fender, Joseph Brady, Bryan T Hennessy, Deborah A McNamara, Elaine Kay, Henk M Verheul, Neerincx Maarten, William M Gallagher, Verena Murphy, Jochen H M Prehn, Miriam Koopman, Cornelis J A Punt, Fotios Loupakis, Matthias P A Ebert, Bauke Ylstra, Diether Lambrechts, Annette T Byrne
Copy number load predicts outcome of metastatic colorectal cancer patients receiving bevacizumab combination therapy. Nature communications 9 (1) (2018)

Hans Prenen.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Hans Prenen